Landmark clinical trial at 22 medical centers finds implanted heart pumps lengthen and improve lives of terminally ill heart failure patients

icant for patients with the device one year after implantation.

Based on the results, the FDA has allowed Thoratec to offer the HeartMate VE to six surviving patients in the medical management arm of the trial. To date, three of these patients have chosen to have the device implanted. The agency also has allowed the company to include an additional 30 patients in the trial.

"The REMATCH data proved to be so significant that Thoratec has submitted it to the FDA to seek approval to make the HeartMate VE available as soon as possible to congestive heart patients who are not eligible for cardiac transplantation," says D. Keith Grossman, president and CEO of Thoratec. "Thoratec is very appreciative of the collaboration among NHLBI, Columbia University, Dr. Rose and each of the investigators that has resulted in the realization of a goal the entire circulatory support industry has been striving toward for decades."

The researchers chose HeartMate VE because it has a textured surface that lowers the probability of clot formation even in the absence of anticoagulant, or clot-preventing, drugs. Thoratec, which provided the devices at no cost and paid for some medical care for the patients, also was willing to put its device through a rigorous randomized trial.

The investigators acknowledge that more research needs to be done to overcome some serious problems with the therapy, including infection and device failure.

"Heart failure affects an estimated 4.7 million Americans, with 550,000 new cases diagnosed each year," says Dr. Claude Lenfant, NHLBI director. "This compelling study shows that even with a high rate of complications, a left ventricular assistance device can provide a significantly longer and better quality of life in extremely ill heart failure patients for whom no other meaningful therapy is available."

With the data from the trial, the investigators are now comparing the cost of implanting the device with the

Contact: Annie Bayne
Columbia University Medical Center

Page: 1 2 3 4

Related medicine news :

1. Landmark survey reveals asthma in children remains significantly out of control in the United States
2. Landmark antidepressant analysis demonstrated significant efficacy of Effexor®/Effexor XR
3. Landmark study shows coenzyme Q10 slows progressive decline in Parkinsons disease
4. Landmark XENDOS study shows Xenical prevents or delays the development of type 2 diabetes
5. Landmark study demonstrates potential for nerve regeneration treatment of stroke
6. Landmark study results published in NEJM highlight breakthrough treatment for heart failure
7. Landmark study uncovers reasons behind recurring back injury
8. Landmark dialysis study findings could greatly simplify treatment of kidney disease with peritoneal dialysis
9. Landmark school-based social influences smoking-prevention program found not to work
10. U.S., British scientific societies honor penicillin as International Chemical Landmark
11. CODE-2*: Landmark study on the costs of type 2 diabetes in Europe

Post Your Comments:

(Date:6/20/2019)... ... June 20, 2019 , ... SightMD (or the ... Founders, announced a strategic partnership with Northern Westchester Ophthalmology, P.C. (“NWO”) and its ... in New York, adding the Company’s first location in Westchester County to SightMD’s ...
(Date:6/19/2019)... ... 19, 2019 , ... The number of public health departments ... of performance continues to climb. Today, the Public Health Accreditation Board ... public health departments. With this week's accreditation decisions, tens of thousands more people ...
(Date:6/19/2019)... ... June 19, 2019 , ... The ... Congress (IRC) in Marseille, France. The conference is widely seen as the ... muscular dystrophy (FSHD). Nearly 200 researchers, clinicians, industry representatives and patient advocates are ...
(Date:6/18/2019)... ... June 18, 2019 , ... EMulate Therapeutics, Inc. ... serious diseases, announced it has received notice that the US Food and Drug ... (HDE) for the Hælo Pediatric system. The FDA granted the Humanitarian Use ...
(Date:6/18/2019)... ST. LOUIS (PRWEB) , ... June 18, 2019 ... ... cost, quality and clinical outcomes, today announced Steve Einig has joined the organization ... will lead strategy and corporate initiatives around market engagement, marketing, strategic events and ...
Breaking Medicine News(10 mins):
(Date:6/19/2019)... RESEDA, California (PRWEB) , ... June 19, 2019 , ... ... women living together at the Los Angeles Jewish Home (LAJH). Known as a destination ... For many seniors, including Edith Frankie, Linda Frankes, and Mildred Moccio, it is also ...
(Date:6/19/2019)... ... June 19, 2019 , ... Center for Vein Restoration (CVR) CEO and ... Top CEOs in 2019 . Glassdoor , one of the world’s largest ... world-class leaders that employees love working for throughout North America and parts of Europe. ...
(Date:6/19/2019)... (PRWEB) , ... June 19, 2019 , ... Senior citizens ... age and this vitality can be a double-edged sword leading seniors to put off ... living specialists and Certified Senior Advisors at Elder Placement Professionals have some suggestions ...
Breaking Medicine Technology:
Cached News: